Here are four observations:
1. OsteoSelect PLUS is a next-generation DBM putty and is comprised of OsteoSelect Putty with demineralized cortical chips.
2. Xtant Medical is prepared to launch OsteoSelect PLUS to customers in the fourth quarter of 2015.
3. This is the first 510(k) approval for Bacterin since becoming a subsidiary of Xtant Medical.
4. Xtant Medical develops and markets regenerative medicine products and medical devices for a number of markets, including orthopedics and neurology.
More articles on devices:
ulrich medical to expand North American corporate division: 4 notes
Exactech shares drop 0.66% — 5 notes
Global neurosurgical products market to reach $7.7B by 2022 & 5 other key trends
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
